We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

BioPharma Credit plc (BPCR) ORD USD0.01

Sell:$0.85 Buy:$0.85 0 Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.85
Buy:$0.85
Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.85
Buy:$0.85
Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BioPharma Credit PLC is a United Kingdom-based specialist debt investor to the life sciences industry. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. It seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. The Company may also invest in equity issued by a life sciences company, acquired directly from the life sciences company or in the secondary market. It will seek to create a diversified portfolio of investments by investing across a range of different forms of debt assets issued by a variety of borrowers. It has two wholly owned subsidiaries: BPCR Limited Partnership and BPCR GP Limited. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its investment manager is Pharmakon Advisors, LP.

Important dates

Future events
There are no future events available.
Past events
Special dividend payment date 29 October 2024 29/10/24
Interim dividend payment date 29 October 2024 29/10/24
Special ex-dividend date 26 September 2024 26/09/24
Interim ex-dividend date 26 September 2024 26/09/24
Interim results 24 September 2024 24/09/24
Interim dividend payment date 31 July 2024 31/07/24
Interim ex-dividend date 04 July 2024 04/07/24
AGM 12 June 2024 12/06/24
Interim dividend payment date 30 April 2024 30/04/24
Interim ex-dividend date 28 March 2024 28/03/24
Annual report 27 March 2024 27/03/24
Final results 27 March 2024 27/03/24
Special dividend payment date 15 March 2024 15/03/24
Interim dividend payment date 15 March 2024 15/03/24
Special ex-dividend date 15 February 2024 15/02/24
Interim ex-dividend date 15 February 2024 15/02/24
Interim dividend payment date 05 January 2024 05/01/24
Special dividend payment date 05 January 2024 05/01/24
General meeting 28 December 2023 28/12/23

General stock information

EPIC:
BPCR
ISIN:
GB00BDGKMY29
Market cap:
$1.01 billion
Shares in issue:
1.19 billion
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
US dollar
Indices:
n/a

Contact details

Address:
51 New North Road
EXETER
EX4 4EP
United Kingdom
Telephone:
+44 (01392) 477503
Website:
bpcruk.com/#

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.